Understanding salinity stress responses in sorghum: exploring genotype variability and salt tolerance mechanisms

Salinity, a significant abiotic stressor, adversely affects global plant growth. To address this, monitoring genetic diversity within a plant species germplasm for salt tolerance traits is vital. This study investigates the responses of ten sorghum genotypes to varying salt stress levels (control, 60 mM NaCl, and 120 mM NaCl), aiming to assess genetic diversity. Using a randomized complete block design with three replications and a split-plot arrangement, salt treatments were assigned to main plots, and genotypes were placed in sub-plots. Physiological attributes, including photosynthetic rate, stomatal conductance, CO2 concentration, leaf area index, chlorophyll concentrations, and antioxidant enzyme activity, were measured during the 50% flowering stage. Fresh forage yield was evaluated at the early dough stage, while dry forage yield and sodium/potassium concentrations were determined post-drying. Salinity induced 10-23% and 21-47% reductions in forage fresh yield at 60 mM and 120 mM NaCl, respectively, across sorghum genotypes. Forage dry yield also declined by 11-33% at 60 mM NaCl and 30-58% at 120 mM NaCl. Increased oxidative stress markers, proline, soluble carbohydrates, and antioxidant enzyme activity accompanied salinity. Genotypes exhibited diverse responses, with Payam showing significant chlorophyll and yield reductions at 60 mM NaCl and notable stress indicators at 120 mM NaCl. Pegah and GS4 demonstrated robust osmoregulation. In stress tolerance indices, Sepideh excelled at 60 mM NaCl, while GS4 outperformed at 120 mM NaCl. Pegah demonstrated high tolerance at 120 mM NaCl. Our findings highlight the importance of combating oxidative stress, managing water-related stress, and maintaining ionic homeostasis for sorghum's salt stress resilience. Key indicators like K/Na ratio, MDA, MSI, SOD, and proline effectively differentiate between tolerant and sensitive genotypes, offering valuable insights for sorghum breeding. Salt-tolerant sorghum genotypes exhibit stable photosynthesis, improved stomatal function, and membrane integrity through efficient osmotic regulation and robust antioxidant enzyme activity. This capability enables them to sustain performance, minimizing final product loss. The results suggest cultivating salt-tolerant sorghum in saline areas for increased sustainable production, with Pegah and GS4 emerging as promising candidates for further testing in salt-affected environments to obtain reliable yield data.

Pullulan-based films impregnated with silver nanoparticles from the Fusarium culmorum strain JTW1 for potential applications in the food industry and medicine

Introduction: Biopolymers, such as pullulan, a natural exopolysaccharide from Aureobasidium pullulans, and their nanocomposites are commonly used in the food, pharmaceutical, and medical industries due to their unique physical and chemical properties. Methods: Pullulan was synthesized by the A. pullulans ATCC 201253 strain. Nanocomposite films based on biosynthesized pullulan were prepared and loaded with different concentrations of silver nanoparticles (AgNPs) synthesized by the Fusarium culmorum strain JTW1. AgNPs were characterized by transmission electron microscopy, Zeta potential measurements, and Fourier-transform infrared spectroscopy. In turn, the produced films were subjected to physico-chemical analyses such as goniometry, UV shielding capacity, attenuated total reflection-Fourier-transform infrared spectroscopy, scanning electron microscopy, and X-ray photoelectron spectroscopy, and their mechanical and degradation properties were assessed. The antibacterial assays of the nanoparticles and the nanocomposite films against both food-borne and reference pathogens, including Listeria monocytogenes, Salmonella infantis, Salmonella enterica, Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Klebsiella pneumoniae, were performed using standard methods. Results: AgNPs were small (mean 15.1 nm), spherical, and displayed good stability, being coated with protein biomolecules. When used in higher concentrations as an additive to pullulan films, they resulted in reduced hydrophilicity and light transmission for both UV-B and UV-A lights. Moreover, the produced films exhibited a smooth surface. Therefore, it can be concluded that the addition of biogenic AgNPs did not change the morphology and texture of the films compared to the control film. The nanoparticles and nanocomposite films demonstrated remarkable antibacterial activity against both food-borne and reference bacteria. The highest activity of the prepared films was observed against L. monocytogenes. Discussion: The obtained results suggest that the novel nanocomposite films prepared from biosynthesized pullulan and AgNPs can be considered for use in the development of medical products and food packaging. Moreover, this is the first report on pullulan-based nanocomposites with mycogenic AgNPs for such applications.

COVID-19 in unvaccinated patients with inborn errors of immunity—polish experience

At the beginning of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic, patients with inborn errors of immunity (IEI) appeared to be particularly vulnerable to a severe course of the disease. It quickly turned out that only some IEI groups are associated with a high risk of severe infection. However, data on the course of Coronavirus Disease 2019 (COVID-19) in patients with IEI are still insufficient, especially in children; hence, further analyses are required. The retrospective study included 155 unvaccinated people with IEI: 105 children and 50 adults (67.7% and 32.3%, respectively). Male patients dominated in the study group (94 people, 60.6%). At least two comorbidities were found in 50 patients (32.3%), significantly more often in adults (56% vs. 21%). Adult patients presented significantly more COVID-19 symptoms. Asymptomatic and mildly symptomatic course of COVID-19 was demonstrated in 74.8% of the entire group, significantly more often in children (88.6% vs. 46%). Moderate and severe courses dominated in adults (54% vs. 11.4%). Systemic antibiotic therapy was used the most frequently, especially in adults (60% vs. 14.3%). COVID-19-specific therapy was used almost exclusively in adults. In the whole group, complications occurred in 14.2% of patients, significantly more often in adults (30% vs. 6.7%). In the pediatric group, there were two cases (1.9%) of multisystem inflammatory syndrome in children. Deaths were reported only in the adult population and accounted for 3.9% of the entire study group. The death rate for all adults was 12%, 15.4% for adults diagnosed with common variable immunodeficiency, 12.5% for those with X-linked agammaglobulinemia, and 21.4% for patients with comorbidity. The results of our study imply that vaccinations against COVID-19 should be recommended both for children and adults with IEI. Postexposure prophylaxis and early antiviral and anti-SARS-CoV-2 antibody-based therapies should be considered in adults with IEI, especially in those with severe humoral immune deficiencies and comorbidity.